Alphatec Holdings is trading 6.77% lower at $9.23, with available evidence identifying no clear catalyst.

  • This compares with the October 1 close of $9.90; the provided price context also shows a 4.07% decline at that close.
  • No October 1–2 company announcement or analyst action was reported to explain the pre-market drop.
  • Healthcare-sector weakness offers context but does not establish a stock-specific cause; major U.S. indices are indicated higher pre-market.